|
|
| This month: The vascular disrupting agent vadimezan, a novel targeted therapy for NSCLC
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Special Focus - Influenza A (H1N1):
Free disease briefing on influenza - updated daily |
|
|
|
|
  SIU 2009
Official Webcasts from the 30th Congress of the Société Internationale d'Urologie
Shangai, China
November 1 - 5, 2009. |
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Myocardial Infarction Targetscape
A diagram showing an overall cellular and molecular landscape or comprehensive network of connections among the current therapeutic targets for the treatment of myocardial infarction and their biological actions. |
|
|
|
|
 International Society Cardiovascular Pharmacotherapy
The ISCP is a society devoted to education and medical research in the field of cardiovascular pharmacotherapy, as well as to the international exchange of information and to the needs of cardiovascular pharmacotherapy with special focus on developing countries. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Drugs of the Future
Proceedings of the International Meeting "Frontiers in Medicinal Chemistry: Emerging Targets, Novel Candidates and Innovative Strategies" (October 4-6, 2009 Barcelona).
|
|
|
Drug News & Perspectives
Magnetic resonance imaging parameters have been established to assess the outcome of acute stroke. A reassessment is made of seven criteria for the validation of these biomarkers of acute ischemic stroke.
|
|
|
|
